Your browser doesn't support javascript.
Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study.
Maximiano Sousa, Filipe; Roelens, Maroussia; Fricker, Brian; Thiabaud, Amaury; Iten, Anne; Cusini, Alexia; Flury, Domenica; Buettcher, Michael; Zukol, Franziska; Balmelli, Carlo; Zimmermann, Petra; Troillet, Nicolas; Vuichard-Gysin, Danielle; Schreiber, Peter W; Bernhard-Stirnemann, Sara; Tschudin-Sutter, Sarah; Nussbaumer-Ochsner, Yvonne; Sommerstein, Rami; Gaudenz, Roman; Marschall, Jonas; Senn, Laurence; Gardiol, Céline; Keiser, Olivia; Schüpbach, Gertraud; Wymann, Monica; Vidondo, Beatriz.
  • Maximiano Sousa F; Swiss Federal Office of Public Health, Bern, Switzerland / Veterinary Public Health Institute, University of Bern, Switzerland.
  • Roelens M; Institute of Global Health, Faculty of Medicine, University of Geneva, Switzerland.
  • Fricker B; Swiss Federal Office of Public Health, Bern, Switzerland / Veterinary Public Health Institute, University of Bern, Switzerlan.
  • Thiabaud A; Institute of Global Health, Faculty of Medicine, University of Geneva, Switzerland.
  • Iten A; Service of Prevention and Infection Control, Directorate of Medicine and Quality, University Hospital Geneva, HUG, Geneva, Switzerland.
  • Cusini A; Department of Infectious Diseases, Cantonal Hospital Graubuenden, Chur, Switzerland.
  • Flury D; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, Switzerland.
  • Buettcher M; Paediatric Infectious Diseases, Department of Paediatrics, Children's Hospital, Cantonal Hospital Lucerne, Switzerland.
  • Zukol F; Paediatric Infectious Diseases, Department of Paediatrics, Cantonal Hospital Winterthur, Switzerland.
  • Balmelli C; Infection Control Programme, EOC Hospitals, Ticino, Switzerland.
  • Zimmermann P; Faculty of Science and Medicine, University of Fribourg, Switzerland / Department of Paediatrics, Fribourg Hospital HFR, Fribourg, Switzerland.
  • Troillet N; Service of Infectious Diseases, Central Institute, Valais Hospitals, Sion, Switzerland.
  • Vuichard-Gysin D; Division of Infectious Diseases and Hospital Hygiene, Thurgau Hospital Group Münsterlingen and Frauenfeld, Switzerland.
  • Schreiber PW; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, Switzerland.
  • Bernhard-Stirnemann S; Children's Hospital Aarau, Switzerland.
  • Tschudin-Sutter S; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel and University of Basel, Switzerland.
  • Nussbaumer-Ochsner Y; Clinic for Internal Medicine, Cantonal Hospital, Hospitals Schaffhausen, Switzerland.
  • Sommerstein R; Department of Infectious Diseases, Bern University Hospital (Inselspital), Bern, Switzerland / Infectious Diseases and Hospital Hygiene, Hirslanden Central Switzerland, Lucerne, Switzerland.
  • Gaudenz R; Internal Medicine and Infectiology, Cantonal Hospital Nidwalden, Stans, Switzerland.
  • Marschall J; Department of Infectious Diseases, Bern University Hospital (Inselspital), Bern, Switzerland.
  • Senn L; Service of Preventive Medicine, Lausanne University Hospital, CHUV, Lausanne, Switzerland.
  • Gardiol C; Swiss Federal Office of Public Health, Bern, Switzerland.
  • Keiser O; Institute of Global Health, Faculty of Medicine, University of Geneva, Switzerland.
  • Schüpbach G; Swiss Federal Office of Public Health, Bern, Switzerland / Veterinary Public Health Institute, University of Bern, Switzerland.
  • Wymann M; Swiss Federal Office of Public Health, Bern, Switzerland.
  • Vidondo B; Swiss Federal Office of Public Health, Bern, Switzerland / Veterinary Public Health Institute, University of Bern, Switzerland.
Swiss Med Wkly ; 151: w20547, 2021 07 19.
Article in English | MEDLINE | ID: covidwho-1332302
ABSTRACT

BACKGROUND:

As clinical signs of COVID-19 differ widely among individuals, from mild to severe, the definition of risk groups has important consequences for recommendations to the public, control measures and patient management, and needs to be reviewed regularly.

AIM:

The aim of this study was to explore risk factors for in-hospital mortality and intensive care unit (ICU) admission for hospitalised COVID-19 patients during the first epidemic wave in Switzerland, as an example of a country that coped well during the first wave of the pandemic.

METHODS:

This study included all (n = 3590) adult polymerase chain reaction (PCR)-confirmed hospitalised patients in 17 hospitals from the hospital-based surveillance of COVID-19 (CH-Sur) by 1 September 2020. We calculated univariable and multivariable (adjusted) (1) proportional hazards (Fine and Gray) survival regression models and (2) logistic regression models for in-hospital mortality and admission to ICU, to evaluate the most common comorbidities as potential risk factors. RESULTS AND

DISCUSSION:

We found that old age was the strongest factor for in-hospital mortality after having adjusted for gender and the considered comorbidities (hazard ratio [HR] 2.46, 95% confidence interval [CI] 2.33−2.59 and HR 5.6 95% CI 5.23−6 for ages 65 and 80 years, respectively). In addition, male gender remained an important risk factor in the multivariable models (HR 1.47, 95% CI 1.41−1.53). Of all comorbidities, renal disease, oncological pathologies, chronic respiratory disease, cardiovascular disease (but not hypertension) and dementia were also risk factors for in-hospital mortality. With respect to ICU admission risk, the pattern was different, as patients with higher chances of survival might have been admitted more often to ICU. Male gender (OR 1.91, 95% CI 1.58−2.31), hypertension (OR  1.3, 95% CI 1.07−1.59) and age 55–79 years (OR 1.15, 95% CI 1.06−1.26) are risk factors for ICU admission. Patients aged 80+ years, as well as patients with dementia or with liver disease were admitted less often to ICU.

CONCLUSION:

We conclude that increasing age is the most important risk factor for in-hospital mortality of hospitalised COVID-19 patients in Switzerland, along with male gender and followed by the presence of comorbidities such as renal diseases, chronic respiratory or cardiovascular disease, oncological malignancies and dementia. Male gender, hypertension and age between 55 and 79 years are, however, risk factors for ICU admission. Mortality and ICU admission need to be considered as separate outcomes when investigating risk factors for pandemic control measures and for hospital resources planning.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hospital Mortality / Pandemics / COVID-19 / Hospitalization Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Aged / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Swiss Med Wkly Journal subject: Medicine Year: 2021 Document Type: Article Affiliation country: Smw.2021.20547

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Hospital Mortality / Pandemics / COVID-19 / Hospitalization Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Aged / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Swiss Med Wkly Journal subject: Medicine Year: 2021 Document Type: Article Affiliation country: Smw.2021.20547